Фирмени съобщения · 13.11.2026 г.1 min read
Leqembi® Pen subcutaneous treatment launched in Japan
Локален автоматичен превод · Оригинален език на източника
Summary
STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…